New Experimental Therapy CAR NKT-Cells Tested In Cancer Patients For The First Time
- OPACC
- May 16, 2019
- 1 min read
CAR T-cells are becoming somewhat of a household name, but a new phase I trial is, for the first time, using CAR 'NKT' cells, featuring genetic modification of a different immune cell, natural killer T-cells. Natural killer T-cells have long been known to be important in mediating the immune system's response to cancer, targeting both tumor cells and cells infected with viruses.
Recent Posts
See AllDuring cancer treatment, children can face hurdles to maintaining healthy eating. Chemotherapy has many side effects, including loss of...
Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
Kommentarer